The Amplifi ID™ Advantage
Rapid Test Process
Conduct a test and get plain language results in 10 minutes or less.
Find out the critical contents of a drug sample, including trace amounts of fentanyl analogues and xylazine.
Easy to Use
No specialized lab expertise required. Have anyone up and running tests within 3 hours of training.
Portable and Field Ready
Fits in any setting, from supervised consumption sites to mobile outreach units, supporting your team wherever you are.
Experience the power of precision in 3 effortless steps
Dilute the drug sample to prepare it for analysis.
Effortlessly scan the prepared sample with the Amplifi ID Reader
Our software analyzes the signal and provides plain language results.
Within just 10 minutes, assess the composition of the drug sample and gain valuable insights.
How it works: Enhanced Molecular Fingerprinting
Proprietary Sensing Platform
Amplifi ID leverages the power of portable Raman spectroscopy and surface enhanced Raman scattering (SERS) to detect unique scattered light signatures from samples.
These signatures are so information rich and specific to organic substances that scientists have coined them “molecular fingerprints”.
Machine Learning Analysis
Our software then uses machine learning algorithms and our own proprietary database of molecular fingerprints collected from physical drug samples to translate fingerprints of an unknown sample into a simple to read result.
Detect what matters most, all on a single test.
Synthetic opioids are far more potent than naturally derived compounds like morphine and heroin, and samples on the illicit market place are rarely pure. Opioid samples are often cut with other compounds (including other unexpected opioids), while they are also often present in samples where no opioids are expected.
Fentanyl is almost never pure. Surveillance of the Toronto Drug supply from 2021-2022 found only 5% of expected fentanyl samples contained NO other active ingredients. It can have dangerous effects when mixed with other active agents like benzodiazepines.
Relative potency (Morphine= 1): 100
Carfentanil is one of the most potent opioids ever synthesized, and is only legally used as a tranquilizer for large mammals. Doses of approximately 5-10 ug/kg body weight are used in sedation.
Relative potency (Morphine= 1): 10,000
A relative newcomer with comparable potency to fentanyl, isotonitazene and other "nitazene" opioids have become a steady presence in the opioid supply.
Relative potency (Morphine= 1): ~200
Benzodiazepines ('Benzos') have extremely powerful synergistic interactions with opioids (and other depressants) which makes them dangerous cutting agents. Although an antagonist does exist to reverse the effects of an overdose (flumazenil), it has a much shorter duration and greater risk of side effects than naloxone. It is therefore not widely distributed for frontline use.
Etizolam is technically a thienodiazepine with distinct structural differences from benzos. Widely available benzodiazepine test kits have had difficulty detecting it.
Estimated relative potency (Diazepam = 1): 5
Estimated relative potency (Diazepam = 1): 40
Estimated relative potency (Diazepam = 1): 130
Xylazine use poses the same dangers as most depressants, with central nervous system depression leading to slowed breathing and lowered heart rate, which may be life-threatening. No known competitive antagonist (naloxone equivalent) to reverse overdose. Chronic xylazine use can cause deoxygenation, which inhibits wound healing, causes severe ulcers, and even lead to amputations in extreme cases.
Amplifi ID™ Dashboard
Take control: Empower your harm reduction efforts with real-time drug intelligence
Get instant access to crucial metrics and analytics to make informed, data-driven decisions. Seamlessly identify emerging trends, detect hazardous mixtures, and optimize resource allocation, all in one place.
It's a revolutionary approach to staying ahead in the battle against the overdose crisis.
Rapid alerts on dangerous samples
Gain an upper hand in community protection with our rapid alert system, providing instant notifications on noteworthy substance discoveries.